Table 5 Comparison between non-invasive markers at fibrosis stages
From: Detection of liver fibrosis stages in patients with hepatitis C virus infection by non-invasive tool
Parameters | F0-F1 | F1-F2 | F2-F3 | F3-F4 | F4-F6 | ANOVA | |
|---|---|---|---|---|---|---|---|
F | P value | ||||||
AAR | 0.89 ± 0.28 | 0.92 + 0.21 | 0.93 ± 0.23 | 1.2 ± 0.33 | 1.4 + 0.41 | 6.092 | 0.003* |
APRI | 0.30 ± 0.1 | 0.71 + 0.42 | 1.15 ± 0.81 | 1.54 ± 1.04 | 1.97 + 0.35 | 11.468 | < 0.001* |
FIB-4 | 0.89 ± 0.63 | 1.7 + 0.92 | 2.35 ± 1.80 | 4.03 ± 4.60 | 6.23 + 2.1 | 8.910 | < 0.001* |
Fibroscan (kpa) | 5.02 ± 1.03 | 7.24 + 1.01 | 9.77 ± 0.32 | 24.41 ± 17.68 | 32.23 + 12.2 | 23.589 | < 0.001* |
S100A14 (ng/ml) | 0.27 ± 0.6 | 0.38 + 0.14 | 0.45 ± 0.17 | 0.52 ± 0.24 | 0.7 + 15 | 5.416 | < 0.002* |